Akdemir E,Sahin E,Madendag Y,Sahin ME,Madendag IC,Acmaz G,Ozdemir F,Muhtaroglu S,Muderris II .2020 .Effect of preeclampsia and preeclampsia severity on insulin homa-ir and betatrophin levels in non-diabetic pregnant women. Placenta, 100 : 54-59.
Anim-Nyame N,Ghosh A,Freestone N,Arrigoni FI .2015 .Relationship between insulin resistance and circulating endothelial cells in pre-eclampsia. Gynecol. Endocrinol., 31(10) : 788-791.
Banerjee RR .2018 .Piecing together the puzzle of pancreatic islet adaptation in pregnancy. , 1411(1) : 120-139.
Baykus Y,Yavuzkir S,Ustebay S,Ugur K,Deniz R,Aydin S R .2019 .Asprosin in umbilical cord of newborns and maternal blood of gestational diabetes, preeclampsia, severe preeclampsia, intrauterine growth retardation and macrosemic fetus. Peptides, 120 : 170132.
Coelho SC,Berillo O,Caillon A,Ouerd S,FraulobAquino JC,Barhoumi T,Offermanns S,Paradis P,Schiffrin EL .2018 .Three-month endothelial human endothelin-1 overexpression causes blood pressure elevation and vascular and kidney injury. Hypertension, 71(1) : 208-216.
Ghosh A,Freestone NS,Anim‐Nyame N,Arrigoni FI .2017 .Microvascular function in pre‐eclampsia is influenced by insulin resistance and an imbalance of angiogenic mediators. Physiol. Rep, 5(8) : E13185.
Hoffmann JG,Xie W,Chopra AR .2020 .Energy regulation mechanism and therapeutic potential of asprosin. Diabetes, 69(4) : 559-566.
Huda SS,Forrest R,Paterson N,Jordan F,Sattar N,Freeman DJ N .2014 .In preeclampsia, maternal third trimester subcutaneous adipocyte lipolysis is more resistant to suppression by insulin than in healthy pregnancy. Hypertension, 63(5) : 1094-1101.
Jung TW,Kim HC,Kim HU,Park T,Park J,Kim U,Kim MK,Jeong JH .2019 .Asprosin attenuates insulin signaling pathway through PKCO‐activated ER stress and inflammation in skeletal muscle. J. Cell. Physiol., 234(11) : 20888-20899.
Khaliq OP,Konoshita T,Moodley J,Naicker T .2018 .The role of uric acid in preeclampsia: is uric acid a causative factor or a sign of preeclampsia? Curr. , 20(9) : 80.
Kun A .2011 .Insulin resistance is associated with gestational hypertension and not with preeclampsia: A population-based screening study. Gynecol. Obstet. Invest., 71(4) : 256-261.
Lee T,Yun S,Jeong JH,Jung TW .2019 .Asprosin impairs insulin secretion in response to glucose and viability through Tlr4/Jnk-mediated inflammation. Mol. Cell, 486 : 96-104.
Lopez-Jaramillo P,Barajas J,Rueda-Quijano SM,LopezLopez C,Felix C C .1838 .Obesity and preeclampsia: Common pathophysiological mechanisms. Front. Physiol., 9 : .
Rana S,Lemoine E,Granger JP,Karumanchi S. A. .2019 .Preeclampsia: Pathophysiology, challenges, and perspectives. Circ. Res., 124(7) : 1094-1112.
Romere C,Duerrschmid C,Bournat J,Constable P,Jain M,Xia F,Saha PK,Del Solar M,Zhu B .2016 .Asprosin: A fasting-induced glucogenic protein hormone. Cell, 165(3) : 566-579.
Sáez T,Toledo F,Sobrevia L F .2019 .Extracellular vesicles and insulin resistance: A potential interaction in vascular dysfunction. Curr. Vasc. Pharmacol., 17(5) : 491-497.
Saxena T,Ali AO,Saxena M .2018 .Pathophysiology of essential hypertension: An update. Expert Rev. Cardiovasc. Ther., 16(12) : 879-887.
Sinha S,Singh GP,Gupta K,Kumar S,Gupta A .2014 .Effect of preeclampsia on insulin sensitivity. Int. J. Appl. Basic Med. Res., 4(1) : 7.
Stepan H,Philipp A,Roth I,Kralisch S,Jank A,Schaarschmidt W,Lossner U,Kratzsch J,Bluher M,Stumvoll M M .2012 .Serum levels of the adipokine zinc-α2-glycoprotein are increased in preeclampsia. J. Endocrinol. Investig., 35(6) : 562-565.
Vilela BS,Vasques ACJ,Cassani RSL,Forti ACE,Pareja JC,Tambascia MA,Investigators B,Geloneze B B .2016 .The Homa-adiponectin (Homa-Ad) closely mirrors the Homa-IR index in the screening of insulin resistance in the brazilian metabolic syndrome study (Brams). Plos One, 11(8) : E0158751.
Wang Y,Qu H,Xiong X,Qiu Y,Liao Y,Chen Y,Zheng Y,Zheng H Y .2018 .Plasma asprosin concentrations are increased in individuals with glucose dysregulation and correlated with insulin resistance and first-phase insulin secretion. Mediators. Inflamm., : 1-7.
Yuan M,Li W,Zhu Y,Yu B,Wu J .2020 .Asprosin: A novel player in metabolic diseases. Front. Endocrinol., 11 : 64.
Zhang X,Jiang H,Ma X,Wu H X .2020 .Increased serum level and impaired response to glucose fluctuation of asprosin is associated with type 2 diabetes mellitus. J. Diabetes Investig., 11(2) : 349-355.